FDA plans ultra-fast review of three psychedelic drugs following Trump directive

The Food and Drug Administration says it will offer ultra-fast review to three psychedelic drugs being studied for hard-to-treat mental health conditions, including depression

Read full article at The Independent →

FDA fast-tracks psychedelics

U.S. FDA plans ultra-fast review of three psychedelic drugs following Trump directive CTV News — Apr 24, 14:55 PM
US FDA plans ultra-fast review of 3 psychedelic drugs after Trump directive South China Morning Post — Apr 24, 14:28 PM
FDA grants quick review for 3 psychedelic drug trials NBC News — Apr 24, 13:00 PM
FDA fast-tracks psychedelic drug research following Trump executive order CNBC — Apr 24, 13:06 PM
FDA plans fast review of 3 psychedelic drugs following Trump directive Boston Globe — Apr 24, 15:03 PM